Pharmacogenomics and pharmacomicrobiomics study of Warfarin

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900026618

Enrollment

Unknown

Registered

2019-10-16

Start date

2019-11-01

Completion date

Unknown

Last updated

2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

warfarin

Interventions

Case series:N/A

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. aged > 18 years; 2. warfarin-naive patients; 3. Patients signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with malignant tumor; 2. Pregnant or lactating women; 3. Patients with severe liveror kidney function dysfunction; 4. Taking antibiotics or prebiotics within the first month of inclusion.

Design outcomes

Primary

Measure	Time frame
Plasma vitamin K concentration;intestinal microflora;	—

Countries

China

Contacts

Public ContactXi Li

Department of Clinical Pharmacology, Xiangya Hospital, Central South University

lixi6931430@126.com+86 13975845413

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026